Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03082482 · ClinicalTrials.gov registry record · NA

Smartphone-delivered Automated Video-assisted Smoking Treatment for People Living With HIV

A NA study, sponsored by University of Oklahoma.

Completed
Registry status
NA
Development phase
20
Enrollment target

NCT03082482: Completed NA study, sponsored by University of Oklahoma.

NCT03082482 is a NA study that has completed, run by University of Oklahoma. The registered enrollment target is 20 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03082482, a NA study, has completed, sponsored by University of Oklahoma.

COMPLETED
Registry status
NA
Development phase
20 participants
Enrollment target

Study Summary

The proposed pilot study seeks to address the smoking treatment needs of people living with HIV/AIDS (PLWHA) by evaluating the feasibility and preliminary efficacy of a smartphone delivered automated video-assisted smoking treatment (AVAST). AVAST will enable smoking cessation treatment content to be presented with voice/audio, images, videos, and text in an interactive, structured format anytime and anywhere. This automated treatment approach is designed to enhance treatment engagement and facilitate abstinence from smoking among PLWHA. Participants will be recruited from the University of Oklahoma Health Sciences Center (OUHSC) clinics providing care to HIV+ individuals (e.g., the Infectious Diseases Institute).

Primary Outcome

Biochemically verifying smoking status on all participants by collecting an expired carbon monoxide breath sample.

Interventions

  • BEHAVIORAL Counseling
  • BEHAVIORAL Self-help materials
  • DRUG nicotine patch
  • OTHER Smartphone-delivered automated treatment

Trial Details

FieldValue
Enrollment Target 20 participants
Start Date 2017-05-15
Est. Completion 2017-12-31
Phase NA
University of Oklahoma

358 total trials

What the finished NCT03082482 record still lists

NCT03082482 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 20 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (99% lower).

The record links to 0 conditions, and to 4 interventions - of which Counseling is the first listed.

NCT03082482 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT03082482 about?

NCT03082482 is a clinical study titled "Smartphone-delivered Automated Video-assisted Smoking Treatment for People Living With HIV". The proposed pilot study seeks to address the smoking treatment needs of people living with HIV/AIDS (PLWHA) by evaluating the feasibility and preliminary efficacy of a smartphone delivered automated video-assisted smoking treatment (AVAST). AVAST will enable smoking cessation treatment content to b...

What is the current status of trial NCT03082482?

This trial is currently completed. It is a NA study. The enrollment target is 20 participants. The study started on 2017-05-15. Estimated completion is 2017-12-31.

What interventions are being tested in trial NCT03082482?

The interventions under investigation include: Counseling (BEHAVIORAL), Self-help materials (BEHAVIORAL), nicotine patch (DRUG), Smartphone-delivered automated treatment (OTHER).

Who is sponsoring clinical trial NCT03082482?

This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT03082482's enrollment target sits among peer trials

20 1768th of 2000 higher than 140 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT00573339 · 20 participants

    Cardiac Magnetic Resonance Imaging (MRI) Normal Reference Control Group Testing

  • NCT00692939 · 20 participants · Phase 1

    Autologous Stem Cell Transplantation for Crohn's Disease

  • NCT00967785 · 20 participants · Phase 1

    A Phase I Study of Mozobil in the Treatment of Patients With WHIMS

  • NCT01406691 · 20 participants · Phase 4

    Light Flashes to Treat Delayed Sleep Phase Disorder (DSPD)

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03082482, the US trial registry maintained by the National Library of Medicine. NCT03082482 (small enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.